Imac Holdings Inc Asset Turnover Ratio (BACK), as of third quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Imac Holdings Inc   (BACK)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

Imac Holdings Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Imac Holdings Inc 's asset turnover ratio, the ratio that measures the ability of Imac Holdings Inc 's assets to generate revenue, sequentially decreased to 0.02 in the third quarter (Sep 30 2025), but it does not raise any concerns as Imac Holdings Inc continue to execute well, and the asset turnover ratio remains above the average.

Within sector Imac Holdings Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2025 compared to previous quarter at no. .

Asset Turnover Ratio Definition



BACK Asset Turnover Ratio (Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
Y / Y Asset Change -78.87 % -51.55 % 25.17 % 38.89 % -65.58 %
Y / Y Revenue Change -62.3 % - - - -96.4 %
Asset Turnover Ratio (TTM) 0.02 - 0.05 - 0.05
BACK's Total Ranking # # # # #
Seq. Asset Change -71.22 % -5.51 % -28.25 % 8.27 % -33.99 %
Seq. Revenue Change - - - - 257.46 %



Asset Turnover Ratio Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2025 Assets at quarter ending Sep 30 2025
Dariohealth Corp   0.20 $ 23.063  Millions$ 115.134  Millions
Zomedica Corp   0.20 $ 30.355  Millions$ 154.433  Millions
Coherus Oncology inc   0.19 $ 83.568  Millions$ 443.895  Millions
Biolife Solutions Inc   0.19 $ 74.005  Millions$ 393.487  Millions
Clearside Biomedical Inc   0.19 $ 3.329  Millions$ 17.942  Millions
Arbutus Biopharma Corp  0.18 $ 14.606  Millions$ 79.704  Millions
Editas Medicine Inc   0.18 $ 46.384  Millions$ 254.393  Millions
Volitionrx Limited  0.18 $ 1.472  Millions$ 8.268  Millions
Syndax Pharmaceuticals Inc   0.18 $ 111.551  Millions$ 628.366  Millions
Petvivo Holdings Inc   0.18 $ 1.088  Millions$ 6.151  Millions
Alector Inc   0.18 $ 69.048  Millions$ 392.078  Millions
Ascendis Pharma A  0.18 $ 249.641  Millions$ 1,424.417  Millions
Moderna Inc   0.18 $ 2,232.000  Millions$ 12,747.750  Millions
Humacyte Inc   0.17 $ 22.958  Millions$ 132.682  Millions
Gossamer Bio Inc   0.17 $ 44.051  Millions$ 261.407  Millions
60 Degrees Pharmaceuticals Inc   0.17 $ 0.944  Millions$ 5.652  Millions
Xencor Inc  0.17 $ 150.132  Millions$ 901.217  Millions
Pacific Biosciences Of California Inc   0.16 $ 154.272  Millions$ 937.466  Millions
Cervomed Inc   0.16 $ 6.160  Millions$ 37.588  Millions
Legend Biotech Corporation  0.16 $ 272.330  Millions$ 1,672.178  Millions
Insmed Inc  0.16 $ 342.104  Millions$ 2,167.140  Millions
Maxcyte inc   0.15 $ 34.418  Millions$ 225.664  Millions
Cannapharmarx Inc   0.15 $ 1.706  Millions$ 11.290  Millions
Femasys Inc   0.15 $ 2.062  Millions$ 13.948  Millions
Kura Oncology Inc   0.15 $ 104.029  Millions$ 708.932  Millions
Ginkgo Bioworks Holdings Inc   0.14 $ 180.606  Millions$ 1,272.771  Millions
Inspiremd Inc   0.14 $ 6.938  Millions$ 49.323  Millions
Nurix Therapeutics Inc   0.14 $ 83.687  Millions$ 599.603  Millions
Skinvisible Inc   0.14 $ 0.020  Millions$ 0.146  Millions
Entrada Therapeutics Inc   0.13 $ 61.520  Millions$ 468.620  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.